Can tumor ablation help organize an immune response? Galvanize’s Aliya PEF data raise a bigger oncology question
A peer-reviewed NSCLC study found mature tertiary lymphoid structures in 47% of Aliya PEF-treated tumors versus 24% of controls, an exploratory signal that now needs clinical validation.
